Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With physician-reviewed results, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Key benefits of Non-HDL Cholesterol / Apolipoprotein B (Non-HDL-C / ApoB) testing

• Measures all cholesterol particles that can clog arteries and cause heart disease.
• Spots cardiovascular risk more accurately than LDL cholesterol alone in many people.
• Guides statin therapy decisions and tracks how well treatment is working.
• Flags hidden risk in people with diabetes, metabolic syndrome, or high triglycerides.
• Clarifies heart disease risk when LDL results don't match your clinical picture.
• Protects long-term heart health by identifying early arterial plaque buildup risk.
• Best interpreted alongside lipid panel, fasting glucose, and cardiovascular risk factors.

What is Non-HDL Cholesterol / Apolipoprotein B (Non-HDL-C / ApoB)?

Non-HDL cholesterol is a calculated measure that captures all the cholesterol carried by potentially harmful particles in your blood. It's simply your total cholesterol minus HDL cholesterol (the "good" kind). This number reflects cholesterol packaged inside lipoproteins that can deposit fat into artery walls, including LDL, VLDL, and remnants.

Apolipoprotein B (ApoB) is the structural protein embedded in each of these atherogenic particles. Every LDL, VLDL, and remnant particle contains exactly one ApoB molecule, making it a direct particle count. Together, non-HDL-C and ApoB tell complementary stories about cardiovascular risk: non-HDL-C measures the cholesterol cargo, while ApoB counts the delivery vehicles.

Why two markers matter more than one

Non-HDL-C is convenient and widely available, but ApoB reveals particle number with precision. Some people have small, cholesterol-light particles that non-HDL-C underestimates.

The cholesterol cargo versus the delivery fleet

Think of non-HDL-C as total freight weight and ApoB as the number of trucks. More trucks mean more opportunities for arterial damage, even if each carries less cargo.

Why is Non-HDL Cholesterol / Apolipoprotein B (Non-HDL-C / ApoB) important?

Non-HDL cholesterol captures all the cholesterol carried by particles that can infiltrate artery walls and drive plaque formation. Apolipoprotein B counts each of those atherogenic particles directly. Together, they offer a sharper window into cardiovascular risk than LDL cholesterol alone, especially when triglycerides are elevated or metabolic conditions cloud the picture.

Every particle tells a story

Lower values reflect fewer atherogenic particles circulating in your bloodstream, which translates to less opportunity for cholesterol to embed in vessel walls. Optimal non-HDL cholesterol typically sits below 130 mg/dL, and apoB below 90 mg/dL, though targets shift based on existing heart disease or diabetes. When these markers fall into favorable ranges, arterial aging slows and long-term cardiovascular events become less likely.

When the numbers climb

Elevated non-HDL or apoB signals an abundance of cholesterol-carrying particles primed to penetrate and inflame artery linings. Over time, this silent process thickens vessel walls, narrows blood flow, and sets the stage for heart attack or stroke. High values often accompany insulin resistance, obesity, or familial lipid disorders, and they predict risk even when standard LDL looks acceptable.

The vascular endgame

These markers integrate lipid transport, inflammation, and metabolic health into a single readout. Tracking them over years reveals how diet, weight, hormones, and genetics shape arterial destiny, making them essential guides for preventing the leading cause of death worldwide.

What do my Non-HDL Cholesterol / Apolipoprotein B (Non-HDL-C / ApoB) results mean?

Low values

Low values usually reflect a reduced number of circulating apolipoprotein B-containing particles, which carry cholesterol and triglycerides from the liver and intestine into the bloodstream. This can occur with malabsorption syndromes, severe liver disease, hyperthyroidism, or genetic conditions affecting lipoprotein assembly. Very low levels may signal impaired fat transport or nutrient absorption, though isolated low values are rarely a clinical concern in otherwise healthy individuals.

Optimal values

Being in range suggests a balanced production and clearance of atherogenic lipoproteins. For cardiovascular risk assessment, optimal tends to sit toward the lower end of the reference range. Non-HDL-C below 130 mg/dL or ApoB below 90 mg/dL is generally associated with lower long-term risk of atherosclerotic disease. ApoB provides a direct particle count and may be more informative than Non-HDL-C when triglycerides are elevated or lipid profiles are discordant.

High values

High values usually reflect an increased number of cholesterol-carrying particles in circulation, driven by overproduction, reduced clearance, or both. This elevates the risk of cholesterol deposition in arterial walls and progression of atherosclerosis. Causes include insulin resistance, obesity, hypothyroidism, nephrotic syndrome, and familial hypercholesterolemia. Women during pregnancy and individuals on certain medications may also show elevated levels.

Notes

Interpretation depends on fasting status, concurrent illness, and medication use. ApoB is less affected by triglyceride levels than Non-HDL-C and may be preferred in metabolic syndrome or diabetes.